BioCorRx (BICX) Current Assets (2010 - 2026)

BioCorRx has disclosed Current Assets across 17 years of filings, most recently posting $1.0 million for Q1 2026.

• Current Assets for Q1 2026 came in at $1.0 million, up 80.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.0 million (up 80.31% YoY), and the FY2025 annual result was $814468.0, up 590.25% from the prior year.
• Current Assets came in at $1.0 million for Q1 2026 at BioCorRx, up from $814468.0 in the prior quarter.
• In the past five years, Current Assets ranged from a high of $1.4 million in Q3 2025 to a low of $117996.0 in Q4 2024.
• The 5-year median for Current Assets is $353097.0 (2024), against an average of $468374.3.
• Across the five-year window, Current Assets sank 70.6% in 2022 and surged 590.25% in 2025, its largest moves.
• BioCorRx's Current Assets stood at $316910.0 in 2022, then tumbled by 40.96% to $187119.0 in 2023, then sank by 36.94% to $117996.0 in 2024, then soared by 590.25% to $814468.0 in 2025, then advanced by 25.26% to $1.0 million in 2026.
• The last three Current Assets figures came in at $1.0 million (Q1 2026), $814468.0 (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.